Genzyme

FABRAZYME

ASP | WAC | AWP at the HCPCS Unit

Manufacturer:

Genzyme

Fabrazyme HCPCS:

J0180

HCPCS Code Descriptor:

Injection, agalsidase beta, 1 mg

Category:

J Code

Fabrazyme NDCs:

58468-0040-01, 58468-0041-01

Primary Type:

Enzyme Replacement Therapy

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Intravenous

Fabrazyme CPT Codes:

Potential CPT administration codes for Fabrazyme can be found at the following link.

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Fabrazyme:

FABRAZYME is an Enzyme Replacement Therapy drug manufactured by Genzyme and administered via the Intravenous route of administration. The J Code: J0180 is aligned to the drug FABRAZYME.

ACCESS PRICING AND MORE BY REGISTERING

J0180 Added Date:

January 1, 2005

J0180 Effective Date:

January 1, 2005

J0180 Termination Date:

HCPCS Active

Fabrazyme billing and coding information can be found through Genzyme at the link below:
Fabrazyme patient assistance information can be found through CareConnectPSS at the URL: https://www.fabrazyme.com/resources-and-support
FABRAZYME prescribing information can be found at the link below:
Information regarding FABRAZYME’s side effects can be found at MedlinePlus